West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 46,400 | 20,200 | 31,900 | 18,400 | -5,200 |
| Depreciation Amortization | 47,400 | 33,200 | 31,200 | 31,200 | 31,900 |
| Income taxes - deferred | 2,700 | -2,500 | 8,700 | 1,900 | 1,400 |
| Accounts receivable | -13,300 | 3,600 | -1,000 | -4,400 | -7,500 |
| Accounts payable and accrued liabilities | 7,100 | -1,900 | N/A | N/A | N/A |
| Other Working Capital | -20,600 | 5,600 | 16,800 | -1,200 | -4,000 |
| Other Operating Activity | 15,900 | 22,800 | -3,900 | 13,200 | 20,900 |
| Operating Cash Flow | $85,600 | $81,000 | $83,700 | $59,100 | $37,500 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -54,100 | -57,400 | -60,400 | -36,000 | -45,200 |
| Net Acquisitions | -174,800 | N/A | N/A | N/A | -1,100 |
| Other Investing Activity | 1,500 | 32,900 | 3,700 | 5,400 | 25,500 |
| Investing Cash Flow | $-227,400 | $-24,500 | $-56,700 | $-30,600 | $-20,800 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -10,000 | 1,400 | 3,400 | -3,500 | 1,700 |
| Debt Repayment | 131,600 | -16,900 | -6,700 | -21,600 | -7,600 |
| Common Stock Issued | 12,200 | 13,500 | 3,000 | 3,300 | 700 |
| Common Stock Repurchased | -800 | -100 | N/A | -100 | -100 |
| Dividend Paid | -14,100 | -12,800 | -11,800 | -11,100 | -10,500 |
| Other Financing Activity | 1,600 | -500 | 0 | 0 | 0 |
| Financing Cash Flow | $120,500 | $-15,400 | $-12,100 | $-33,000 | $-15,800 |
| Exchange Rate Effect | -6,200 | 2,000 | 4,600 | 2,500 | -2,100 |
| Beginning Cash Position | 68,800 | 37,800 | 33,200 | 42,100 | 42,700 |
| End Cash Position | 48,800 | 68,800 | 37,800 | 33,200 | 42,100 |
| Net Cash Flow | $-20,000 | $31,000 | $4,600 | $-8,900 | $-600 |
| Free Cash Flow | |||||
| Operating Cash Flow | 85,600 | 81,000 | 83,700 | 59,100 | 37,500 |
| Capital Expenditure | -54,100 | -57,400 | -60,400 | -36,000 | -45,200 |
| Free Cash Flow | 31,500 | 23,600 | 23,300 | 23,100 | -7,700 |